Publication Name	World Journal of Gastroenterology
Manuscript ID	94781
Country	Italy

Received	2024-03-25 10:42
Peer-Review Started	2024-03-25 10:42
To Make the First Decision
Return for Revision	2024-05-09 23:58
Revised	2024-05-20 19:39
Second Decision	2024-06-06 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-06 05:45
Articles in Press	2024-06-06 05:45
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-06-11 19:52
Typeset the Manuscript	2024-06-17 02:32
Publish the Manuscript Online	2024-07-01 07:39

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Editorial
Article Title	Risk of hepatic decompensation from hepatitis B virus reactivation in hematological malignancy treatments
Manuscript Source	Invited Manuscript
All Author List	Michele Barone
ORCID	Author(s) ORCID Number Michele Barone http://orcid.org/0000-0001-8284-5127
Funding Agency and Grant Number
Corresponding Author	Michele Barone, MD, PhD, Adjunct Associate Professor, Section of Gastroenterology, Department of Precision and Regenerative Medicine - Jonian Area- University of Bari, Piazza G Cesare 11, Bari 70124, Italy. michele.barone@uniba.it
Key Words	Hematological malignancy; Hepatitis; Hepatitis B virus-DNA; Bruton's tyrosine kinase; Previously resolved hepatitis B virus infection
Core Tip	All literature data on the risk of hepatitis B virus (HBV) reactivation in patients with a previously resolved HBV infection and treated with tyrosine kinase inhibitors (TKIs) for their hematologic malignancies are based on retrospective studies. Different risks of HBV reactivation (HBVr) in these patients may depend on the type of hematologic malignancy, the type of therapy (TKIs or Bruton's tyrosine kinase inhibitors), previous exposure to an anti CD20 as first-line therapy, and both ethnicity and HBV genotype. Therefore, the warning regarding HBVr in this specific clinical setting requires further investigation.
Publish Date	2024-07-01 07:39
Citation	<p>Barone M. Risk of hepatic decompensation from hepatitis B virus reactivation in hematological malignancy treatments. <i>World J Gastroenterol</i> 2024; 30(25): 3147-3151</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i25/3147.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i25.3147

Full Article (PDF)	WJG-30-3147-with-cover.pdf
Manuscript File	94781-Review-Filipodia.docx
Answering Reviewers	94781-answering-reviewers.pdf
Audio Core Tip	94781-audio.m4a
Conflict-of-Interest Disclosure Form	94781-conflict-of-interest-statement.pdf
Copyright License Agreement	94781-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	94781-non-native-speakers.pdf
Peer-review Report	94781-peer-reviews.pdf
Scientific Misconduct Check	94781-scientific-misconduct-check.png
Scientific Editor Work List	94781-scientific-editor-work-list.pdf
CrossCheck Report	94781-crosscheck-report.pdf
CrossCheck Report	94781-crosscheck-report.png